Inflammatory Bowel Disease Models Research using animal models of IBD (both Crohn's-like and ulcerative colitis-like conditions) has shown BPC-157 [12]: Reduces intestinal inflammation Accelerates mucosal healing Preserves intestinal barrier function Decreases inflammatory cytokine production Prevents fistula formation in some models Intestinal Anastomosis Healing Surgical studies demonstrated that BPC-157 significantly improves the healing of intestinal anastomoses (surgical connections), potentially reducing complications like leakage and stricture formation [13]
Recent studies have shown that the three, alone or in combination, significantly upregulate GPX1 expression, effectively scavenging intracellular hydrogen peroxide and organic peroxides, reducing ROS accumulation, and enhancing antioxidant defence
These discoveries have transformed mushrooms from traditional health remedies into important subjects of modern biochemical and pharmacological research, supporting their development as therapeutic and nutraceutical agents ( Figure 1 )
Cell Reports , 28 (12), 30113021.e4
Available at: Setchell KD, Gosselin SJ, Welsh MB, Johnston JO, Balistreri WF, Kramer LW, Dresser BL, Tarr MJ
Solubility & Stability
